...
首页> 外文期刊>Asian journal of surgery >Nonoperative management for perforated peptic ulcer: Who can benefit?
【24h】

Nonoperative management for perforated peptic ulcer: Who can benefit?

机译:穿孔性消化性溃疡的非手术治疗:谁可以受益?

获取原文
           

摘要

Summary Background Although nonoperative management for perforated peptic ulcer (PPU) has been used for several decades, the indication is still unclear. A clinicoradiological score was sought to predict who can benefit from it. Methods A clinicoradiological protocol for the assessment of patients presenting with PPU was used. A logistic regression model was applied to identify determinant variables and construct a clinical score that would identify patients who can be successfully treated with nonoperative management. Results Of 241 consecutive patients with PPU, 107 successfully received nonoperative management, and 134 required surgery. In multivariable analysis, the following four variables correlated with surgery and were given one point each toward the clinical score: age ≥70 years, fluid collection detection by ultrasound, contrast extravasation detection by water-soluble contrast examination, and Acute Physiology and Chronic Health Evaluation II (APACHE II) score ≥8. Eighty-five percent of patients with a score of 1 or less were successfully treated with nonoperative management, whereas 23 of 29 patients with a score of 3 or more required surgery. The area under the receiver operating characteristic curve was 0.804 (95% confidence interval?=?0.717–0.891). Conclusion By combining clinical, radiological parameters, and APACHE II score, the clinical score allowed early identification of PPU patients who can benefit from nonoperative management.
机译:概述背景尽管穿孔性消化性溃疡(PPU)的非手术治疗已经使用了数十年,但其适应症仍不清楚。寻求临床放射学评分来预测谁可以从中受益。方法采用临床放射学方案评估PPU患者。应用逻辑回归模型确定行列式变量并构建临床评分,以识别可以通过非手术治疗成功治疗的患者。结果连续241例PPU患者中,有107例成功接受了非手术治疗,其中134例需要手术。在多变量分析中,以下四个变量与手术相关,并分别针对临床得分:年龄≥70岁,超声检查液体收集,水溶性造影剂检查造影剂渗出以及急性生理学和慢性健康评估II(APACHE II)得分≥8。得分为1或更低的患者中有百分之八十五接受了非手术治疗,而得分为3或更高的29位患者中有23位需要手术治疗。接收器工作特性曲线下的面积为0.804(95%置信区间?=?0.717–0.891)。结论通过结合临床,放射学参数和APACHE II评分,该临床评分可以早期识别可从非手术治疗中受益的PPU患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号